Bcl-2/Bad/mPTP pathway mediates 14-3-3γ protecting against LPS-induced myocardial injury

Chinese Pharmacological Bulletin

Volumn 29, Issue 1, 2013, Pages 48-52

  Liu, Dan ^a   Peng, Yi An ^a   Liu, Zhuo Qi ^a   Tang, Lei ^a   Yin, Dong ^a   He, Ming ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Bad; Bcl 2; Lipopolysaccharide; Mitochondria; mPTP; Myocardial injury; Plasmid transfection

Indexed keywords

BAG 1 PROTEIN; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PFLAG 14 3 3 GAMMA PROTEIN; PROTEIN BAD; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL SWELLING; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME ANALYSIS; FLOW CYTOMETRY; GENETIC TRANSFECTION; HEART MITOCHONDRION; HEART MUSCLE INJURY; IN VITRO GENE TRANSFER; NEWBORN; NONHUMAN; PROTEIN FUNCTION; RAT; RECOMBINANT PLASMID; SUPERNATANT; WESTERN BLOTTING;

EID: 84875257715     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2013.01.011     Document Type: Article

References (12)

1. He M, Zhang J, Shao L, et al. Upregulation of 14-3-3 isoforms in acute rat myocardial injuries induced by burn and lipopolysaccharide[J]. Clin Exp Pharmacol Physiol, 2006, 33(4): 374-80.
2. Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure[J]. Am J Physiol Heart Circ Physiol, 2011, 301(6): H2181-90.
3. Hüttemann M, Helling S, Sanderson T H, et al. Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation[J]. Biochim Biophys Acta, 2012, 1817(4): 598-609.
4. Aitken A. 14-3-3 proteins: a historic overview[J]. Semin Cancer Biol, 2006, 16(3): 162-72. (Pubitemid 43796128)
5. Liu D, Yin D, Liao Z P, et al. p38MAPK/14-3-3γ signal pathway may be involved in LPS preconditioning against cardiomyocytes anoxia/reoxygenation injury[J]. Chin Pharmacol Bull, 2012, 28(29): 1239-43.
6. Hollander J M, Baseler W A, Dabkowski E R. Proteomic remodeling of mitochondria in heart failure[J]. Congest Heart Fail, 2011, 17(6): 262-8.
7. Kinnally K W, Peixoto P M, et al. Is mPTP the gatekeeper for necrosis, apoptosis, or both[J]. Biochim Biophys Acta, 2011, 1813(4): 616-22.
8. Javadov S, Hunter J C, Barreto-Torres G, et al. Targeting the mitochondrial permeability transition: cardiac ischemia-reperfusion versus carcinogenesis[J]. Cell Physiol Biochem, 2011, 27(3-4): 179-90.
9. Morin D, Assaly R, Paradis S, et al. Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection[J]. Curr Med Chem, 2009, 16(33): 4382-98.
10. Akopova O V, Kolchinskaya L I, Nosar V I, et al. Cytochrome C as an amplifier of ROS release in mitochondria[J]. Fiziol Zh, 2012, 58(1): 3-12.
11. Zhao J, Meyerkord C L, Du Y, et al. 14-3-3 proteins as potential therapeutic targets[J]. Semin Cell Dev Biol, 2011, 22(7): 705-12.